Loading…
Intelligent Bio Solutions Inc
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in INBS.
▼ -100.0% over 5Y.
today you would have $0.28▼ -100.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 7 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Year-end price | $1.70 | $9.53 | $14.00 | $40.56 | $480.00 | $3,444.00 | $17,760.00 | |
| P/S | 2.8x | 1.2x | 2.8x | 1.9x | 0.6x | 6.8x | 10.8x | 338.4x |
| P/B | 0.8x | 0.9x | 2.9x | 0.7x | 0.2x | 0.4x | 1.4x | — |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| BOLTBolt Biotherapeutics, Inc. | $3.71 | — | 0.6x | — | -111.65% | $7.15M |
| CURXCuranex Pharmaceuticals Inc | $4.56 | — | 1.4x | — | -411.08% | $7.15M |
| CANFCan-Fite BioPharma Ltd. | $3.40 | — | 0.8x | — | -178.24% | $7.28M |
| INMInMed Pharmaceuticals Inc. | $1.38 |
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
Company description provided by Yahoo Finance.
| EPS | -$8.44 | -$20.04 | -$63.80 | -$1,270.00 | -$1,359.60 | -$1,632.00 | -$888.00 |
| Profit margin | -355.33% | -294.91% | -346.23% | -326.40% | -845.89% | -1900.06% | -355.33% | -1676.23% |
| ROE | -175.47% | -225.57% | -352.75% | -121.94% | -279.86% | -125.38% | -46.74% | — |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 0.7x |
| — |
| -112.65% |
| $7.37M |
| ACONAclarion, Inc. | $2.40 | — | 0.3x | — | -58.97% | $6.92M |
| NVNOenVVeno Medical Corp | $10.75 | — | 0.4x | — | -58.53% | $7.47M |